SCHEMBL2879345

SCHEMBL2879345

COC(=O)CC[CH]CCO

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.52
LMNA P02545 3/20 0.44
ALDH1A1 P00352 2/20 0.44
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
AKT1 P31749 1/20 0.40
CA12 O43570 3/20 0.39
CA14 Q9ULX7 3/20 0.39
KDM4E B2RXH2 1/20 0.39
HSD17B10 Q99714 2/20 0.38
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.38
MGAM O43451 1/20 0.37
GAA P10253 1/20 0.37
SI P14410 1/20 0.37
MGAM2 Q2M2H8 1/20 0.37
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
RECQL P46063 1/20 0.34
CYP4F2 P78329 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17165778 0.91 TSHR (0.63) TSHRLMNAALDH1A1KMT2AMEN1
SCHEMBL1619486 0.79
SCHEMBL19890782 0.77 AKT1 (0.47) TSHRLMNAALDH1A1AKT1MAPT
SCHEMBL10958690 0.77 TSHR (0.46) TSHRLMNAALDH1A1KMT2AMEN1
SCHEMBL18396659 0.77 TSHR (0.46) TSHRLMNAALDH1A1KMT2AMEN1
SCHEMBL9188658 0.75 TSHR (0.63) TSHRLMNAALDH1A1KMT2AMEN1
SCHEMBL2401513 0.75 TSHR (0.63) TSHRLMNAALDH1A1KMT2AMEN1
SCHEMBL2401509 0.75 TSHR (0.63) TSHRLMNAALDH1A1KMT2AMEN1
SCHEMBL8903586 0.75 TSHR (0.44) TSHRLMNAALDH1A1KMT2AMEN1
SCHEMBL95588 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2120913-B1 NANOPARTICLE AND POLYMER FORMULATIONS FOR THYROID HORMONE ANALOGS, ANTAGONISTS, AND FORMULATIONS AND USES THEREOF NANOPHARMACEUTICALS LLC (US) 2015-01-21 EP claimed
JP-2010513526-A 2010-04-30 JP claimed
EP-2120913-A2 NANOPARTICLE AND POLYMER FORMULATIONS FOR THYROID HORMONE ANALOGS, ANTAGONISTS, AND FORMULATIONS AND USES THEREOF CLF Medical Technology Acceleration Program, Inc. (US) 2009-11-25 EP claimed
WO-2008140507-A9 NANOPARTICLE AND POLYMER FORMULATIONS FOR THYROID HORMONE ANALOGS, ANTAGONISTS, AND FORMULATIONS AND USES THEREOF CLF MEDICAL TECHNOLOGY ACCELERATION PROGRAM INC (US) 2009-02-19 WO claimed
EP-2018186-A2 NANOPARTICLE AND POLYMER FORMULATIONS FOR THYROID HORMONE ANALOGS, ANTAGONISTS, AND FORMULATIONS THEREOF Ordway Research Institute, Inc. (US) 2009-01-28 EP claimed
WO-2008140507-A2 NANOPARTICLE AND POLYMER FORMULATIONS FOR THYROID HORMONE ANALOGS, ANTAGONISTS, AND FORMULATIONS AND USES THEREOF CLF MEDICAL TECHNOLOGY ACCELERATION PROGRAM, INC. (US) 2008-11-20 WO claimed
WO-2008051291-A2 NANOPARTICLE AND POLYMER FORMULATIONS FOR THYROID HORMONE ANALOGS, ANTAGONISTS, AND FORMULATIONS THEREOF ORDWAY RESEARCH INSTITUTE (US) 2008-05-02 WO claimed
EP-1793814-B1 THYROID HORMONE ANALOGS FOR INHIBITING ANGIOGENESIS NANOPHARMACEUTICALS LLC (US) 2015-01-21 EP disclosed
EP-2120913-B1 NANOPARTICLE AND POLYMER FORMULATIONS FOR THYROID HORMONE ANALOGS, ANTAGONISTS, AND FORMULATIONS AND USES THEREOF NANOPHARMACEUTICALS LLC (US) 2015-01-21 EP disclosed
EP-2120913-A2 NANOPARTICLE AND POLYMER FORMULATIONS FOR THYROID HORMONE ANALOGS, ANTAGONISTS, AND FORMULATIONS AND USES THEREOF CLF Medical Technology Acceleration Program, Inc. (US) 2009-11-25 EP disclosed
WO-2008140507-A9 NANOPARTICLE AND POLYMER FORMULATIONS FOR THYROID HORMONE ANALOGS, ANTAGONISTS, AND FORMULATIONS AND USES THEREOF CLF MEDICAL TECHNOLOGY ACCELERATION PROGRAM INC (US) 2009-02-19 WO disclosed
WO-2008140507-A2 NANOPARTICLE AND POLYMER FORMULATIONS FOR THYROID HORMONE ANALOGS, ANTAGONISTS, AND FORMULATIONS AND USES THEREOF CLF MEDICAL TECHNOLOGY ACCELERATION PROGRAM, INC. (US) 2008-11-20 WO disclosed